GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Total Liabilities

Curatis Holding AG (XSWX:CURN) Total Liabilities : CHF13.72 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Total Liabilities?

Curatis Holding AG's Total Liabilities for the quarter that ended in Jun. 2024 was CHF13.72 Mil.

Curatis Holding AG's quarterly Total Liabilities declined from Jun. 2023 (CHF5.99 Mil) to Dec. 2023 (CHF0.43 Mil) but then increased from Dec. 2023 (CHF0.43 Mil) to Jun. 2024 (CHF13.72 Mil).

Curatis Holding AG's annual Total Liabilities increased from Dec. 2021 (CHF0.54 Mil) to Dec. 2022 (CHF7.29 Mil) but then declined from Dec. 2022 (CHF7.29 Mil) to Dec. 2023 (CHF0.43 Mil).


Curatis Holding AG Total Liabilities Historical Data

The historical data trend for Curatis Holding AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Total Liabilities Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Total Liabilities
0.54 7.29 0.43

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial 16.74 7.29 5.99 0.43 13.72

Curatis Holding AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Curatis Holding AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.299+(0.133+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=0.43

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=0.12--0.312
=0.43

Curatis Holding AG's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.755+(0+6.963
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=13.72

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=55.311-41.593
=13.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.